FIELD: medicine.
SUBSTANCE: invention relates to experimental medicine. Nanocomposites for luminescent diagnostics and diagnostics of neoplasms include ytterbium complexes of dimethyl ether of protoporphyrin IX, or tetramethyl ether of hematoporphyrin IX, or coproporphyrin III, placed in a polymer shell based on lexan. Nanocomposites additionally contain a core of Fe3O4 magnetite with a core diameter of 10-20 nm. The size of the nanoparticles is 150-200 nm.
EFFECT: invention makes it possible to increase the lifetime and luminescence intensity of ytterbium porphyrin complexes in the near-IR region of the spectrum for effective local magneto-luminescent theranostics of neoplasms.
1 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NANOCOMPOSITION FOR FLUORESCENT DIAGNOSIS OF MALIGNANT TUMOURS | 2014 |
|
RU2578976C2 |
| PHARMACEUTICAL COMPOSITION FOR FLUORESCENT DIAGNOSTICS OF PATHOLOGICAL CHANGES IN SKIN AND MUCOUS MEMBRANES | 2016 |
|
RU2617045C1 |
| YTTERBIUM TETRAPYRAZOLYL PORPHYRIN COMPLEXES AS FLUORESCENT TAGS TO DIAGNOSE MALIGNANT GROWTHS | 2008 |
|
RU2372099C1 |
| YTTERBIUM COMPLEX OF 2,4-DIMETHOXYHEMATOPORPHYRIN IX DIPOTASSIUM SALT AS FLUORESCENT TAG FOR EARLY CANCER DIAGNOSIS | 2009 |
|
RU2411243C1 |
| COMPOSITE NANOPARTICLES FOR PHOTODYNAMIC DIAGNOSIS | 2011 |
|
RU2463074C1 |
| METHOD OF PRODUCING A DIPOTASSIUM SALT OF THE 2,4-DI(α-METHOXYETHYL)DEUTEROPORPHYRIN IX ACETYLACETONATE YTTERBIUM COMPLEX | 2019 |
|
RU2697418C1 |
| NANOCOMPOSITES BASED ON GADOLINIUM-CONTAINING COMPOUNDS FOR DIAGNOSIS, THERAPY, AND THERANOSTICS OF ONCOLOGICAL DISEASES OF THE BRAIN AND METHODS FOR PRODUCTION THEREOF | 2021 |
|
RU2778928C1 |
| DEVICE FOR LUMINISCENT DIAGNOSTICS OF NEOPLASMS | 2012 |
|
RU2483678C1 |
| METHOD FOR INVESTIGATING TISSUE MALIGNANCY PROCESS IN EXPERIMENTAL ANIMALS | 1988 |
|
SU1621720A1 |
| METHOD FOR PRODUCING COMPLEX FOR TUMOR THERAPEUTICS BASED ON ANTI-STOKES NANOPHOSPHORS AND PROTEIN MOLECULES | 2020 |
|
RU2745187C1 |
